1
|
Zhu G, Wang X, Wang F, Mao Y, Wang H. New and Convergent Synthesis of Osimertinib. J Heterocycl Chem 2017. [DOI: 10.1002/jhet.2898] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Guoqing Zhu
- College of Chemistry and Chemical Engineering; Shanghai University of Engineering Science; Shanghai 201620 China
| | - Xingyan Wang
- College of Chemistry and Chemical Engineering; Shanghai University of Engineering Science; Shanghai 201620 China
| | - Feng Wang
- College of Chemistry and Chemical Engineering; Shanghai University of Engineering Science; Shanghai 201620 China
| | - Yongjun Mao
- College of Chemistry and Chemical Engineering; Shanghai University of Engineering Science; Shanghai 201620 China
| | - Han Wang
- College of Chemistry and Chemical Engineering; Shanghai University of Engineering Science; Shanghai 201620 China
| |
Collapse
|
2
|
Mohana Roopan S, Sompalle R. Synthetic chemistry of pyrimidines and fused pyrimidines: A review. SYNTHETIC COMMUN 2016. [DOI: 10.1080/00397911.2016.1165254] [Citation(s) in RCA: 49] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
3
|
A green four-component synthesis of 2-amino-3-cyano-4-aryl-6-sulfanepyrimidine in water solvent using phase-transfer catalyst. JOURNAL OF THE IRANIAN CHEMICAL SOCIETY 2015. [DOI: 10.1007/s13738-015-0770-1] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
4
|
Shameem M, Kumar R, Krishna S, Kumar C, Siddiqi MI, Kundu B, Banerjee D. Synthetic modified pyrrolo[1,4] benzodiazepine molecules demonstrate selective anticancer activity by targeting the human ligase 1 enzyme: An in silico and in vitro mechanistic study. Chem Biol Interact 2015; 237:115-24. [PMID: 26079053 DOI: 10.1016/j.cbi.2015.05.024] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2015] [Revised: 05/15/2015] [Accepted: 05/26/2015] [Indexed: 11/18/2022]
Abstract
Human DNA ligase1 (hLig1) is the major replicative enzyme in proliferating mammalian cells that join Okazaki fragments of the lagging strand during DNA replication. Interruptions in the process of ligation cause DNA damage to accumulate, resulting in cytotoxicity and cell death. In the present study we demonstrate that pyrrolo[1,4] benzodiazepine (PBD) derivatives exhibit anticancer properties by targeting the nick sealing activity of hLig1 as opposed to the DNA interaction activity known for such compounds. Our in silico and in vitro assays demonstrate the binding of these molecules with amino acid residues present in the DNA binding domain (DBD) of the hLig1 enzyme. Two of these hLig1 inhibitors S010-015 and S010-018 demonstrated selective cytotoxicity against DLD-1 (colon cancer) and HepG2 (hepatic cancer) cells in a dose dependant manner. The molecules also reduced cell viability and colony formation at concentrations of ⩽20μM in DLD-1 and HepG2 cells and induced apoptotic cell death. In yet another significant finding, the molecules reduced the migration of cancer cells in wound healing experiments, indicating their anti-metastatic property. In summary, we report the anticancer activity of PBD derivatives against DLD-1 and HepG2 cells and propose a new molecular target for their activity.
Collapse
Affiliation(s)
- Mohammad Shameem
- Molecular and Structural Biology Division, CSIR-Central Drug Research Institute, B.S. 10/1, Janakipuram Extension, Sitapur Road, Lucknow 226031, India
| | - Ravi Kumar
- Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, B.S. 10/1, Janakipuram Extension, Sitapur Road, Lucknow 226031, India
| | - Shagun Krishna
- Molecular and Structural Biology Division, CSIR-Central Drug Research Institute, B.S. 10/1, Janakipuram Extension, Sitapur Road, Lucknow 226031, India
| | - Chandan Kumar
- Molecular and Structural Biology Division, CSIR-Central Drug Research Institute, B.S. 10/1, Janakipuram Extension, Sitapur Road, Lucknow 226031, India
| | - Mohammad Imran Siddiqi
- Molecular and Structural Biology Division, CSIR-Central Drug Research Institute, B.S. 10/1, Janakipuram Extension, Sitapur Road, Lucknow 226031, India
| | - Bijoy Kundu
- Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, B.S. 10/1, Janakipuram Extension, Sitapur Road, Lucknow 226031, India.
| | - Dibyendu Banerjee
- Molecular and Structural Biology Division, CSIR-Central Drug Research Institute, B.S. 10/1, Janakipuram Extension, Sitapur Road, Lucknow 226031, India.
| |
Collapse
|
5
|
Kamal A, Ramakrishna G, Ramaiah MJ, Viswanath A, Rao AVS, Bagul C, Mukhopadyay D, Pushpavalli SNCVL, Pal-Bhadra M. Design, synthesis and biological evaluation of imidazo[1,5-a]pyridine–PBD conjugates as potential DNA-directed alkylating agents. MEDCHEMCOMM 2013. [DOI: 10.1039/c2md20219k] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
6
|
Synthesis pharmacological evaluation and docking studies of pyrimidine derivatives. Eur J Med Chem 2012; 58:478-84. [DOI: 10.1016/j.ejmech.2012.09.050] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2012] [Revised: 09/27/2012] [Accepted: 09/28/2012] [Indexed: 12/11/2022]
|
7
|
Kamal A, Ramakrishna G, Lakshma Nayak V, Raju P, Subba Rao A, Viswanath A, Vishnuvardhan M, Ramakrishna S, Srinivas G. Design and synthesis of benzo[c,d]indolone-pyrrolobenzodiazepine conjugates as potential anticancer agents. Bioorg Med Chem 2012; 20:789-800. [DOI: 10.1016/j.bmc.2011.12.003] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2011] [Revised: 11/30/2011] [Accepted: 12/01/2011] [Indexed: 10/14/2022]
|
8
|
Rotas G, Kimbaris A, Varvounis G. Synthesis of a novel pyrrolo[1,2-c][1.3]benzodiazepine analogue of VPA-985. Tetrahedron 2011. [DOI: 10.1016/j.tet.2011.07.083] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
9
|
Kamal A, Reddy MK, Ramaiah MJ, Srikanth YVV, Rajender, Reddy VS, Kumar GB, Pushpavalli SNCVL, Bag I, Juvekar A, Sen S, Zingde SM, Pal-Bhadra M. Synthesis of Aryl-Substituted Naphthalene-Linked Pyrrolobenzodiazepine Conjugates as Potential Anticancer Agents with Apoptosis-Inducing Ability. ChemMedChem 2011; 6:1665-79. [DOI: 10.1002/cmdc.201100207] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2011] [Revised: 06/08/2011] [Indexed: 11/11/2022]
|
10
|
Synthesis and biological evaluation of estradiol linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates as potential anticancer agents. Bioorg Med Chem 2011; 19:2565-81. [DOI: 10.1016/j.bmc.2011.03.015] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2011] [Accepted: 03/07/2011] [Indexed: 01/08/2023]
|
11
|
Antonow D, Thurston DE. Synthesis of DNA-Interactive Pyrrolo[2,1-c][1,4]benzodiazepines (PBDs). Chem Rev 2010; 111:2815-64. [DOI: 10.1021/cr100120f] [Citation(s) in RCA: 146] [Impact Index Per Article: 10.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- Dyeison Antonow
- Gene Targeting Drug Design Research Group, The School of Pharmacy, University of London, 29/39 Brunswick Square, London WC1N 1AX, U.K
| | - David E. Thurston
- Gene Targeting Drug Design Research Group, The School of Pharmacy, University of London, 29/39 Brunswick Square, London WC1N 1AX, U.K
- Spirogen Ltd., 29/39 Brunswick Square, London WC1N 1AX, U.K
| |
Collapse
|